Skip to main content

Table 4 Cost-effectiveness ratio in US $, 2008-dated [equivalent US $, 2017-dated] for one-dose and two-dose varicella vaccine in Colombia [64]

From: Burden of varicella in Latin America and the Caribbean: findings from a systematic literature review

Cost One-Dose Vaccine Compared With No Vaccine
(ACER)
Two-Dose Vaccine Compared With No Vaccine
(ACER)
Two-Dose Vaccine Compared With One-Dose Vaccine
(ICER)
Cost per avoided consultation $9 (equivalent to $12.5) $21 (equivalent to $29.2) $119 (equivalent to $165.4)
Cost per avoided hospitalization $4893 (equivalent to $5681.9) $11,127 (equivalent to $11,5463.7) $64,110 (equivalent to $89,096.7)
Cost per avoided death $75,187 (equivalent to $87,309.1) $170,962 (equivalent to $237,594.0) $983,977 (equivalent to $1,367,479.3)
Cost per LYG $2519 (equivalent to $3318.76) $5728 (equivalent to $6305.69) $33,002 (equivalent to $43,479.91)
Cost per DALY averted $1362 (equivalent to $1892.8) $3097 (equivalent to $4304.1) $17,844 (equivalent to $24,798.7)
  1. ACER average cost-effectiveness ratio; DALY disability adjusted life-years; ICER incremental cost-effectiveness ratio; LYG life-years gained